Infusion Nursing Notes by Nufactor provides education, resources and support to promote successful patient therapy within the infusion nursing community.

Troubleshooting Implanted Ports

As a health care provider in the home setting, coming across various types of venous access devices is expected. Access devices can vary from peripherally inserted catheters for short-term or intermittently administered therapies, such as IVIG or infliximab, to centrally placed devices for long-term use, especially if there are venous access problems. A physician and patient should discuss and decide on the most appropriate venous access device while considering the duration of therapy, lifestyle, and history of venous access issues. Nurses are expected to maintain various types of central venous access devices (CVADs), such as peripherally inserted central catheters (PICCs), central venous catheters (CVCs) such as Hickman™ and Broviac™ catheters, and implanted ports. Patients may already have a CVAD when admitted for home infusion therapy services or require placement after admission if they have poor or inaccessible venous access and the need for long-term therapy. This blog will focus on handling and troubleshooting ports. [More]

Positivity

Happy New Year! This is a time of fresh starts, new beginnings, and starting over again, but a calendar doesn’t have to determine when you make decisions about your life to make improvements. In fact, living a positive life is a process, not an event. It’s something that is a conscious and active decision every day, no matter what is going on in your life. Easier said than done, right? [More]

Gratitude

Let’s start by taking a couple of deep breaths, inhale through your nose and slowly exhale out through your mouth (smell the flowers and blow out the candles is how I like to say it). Starting your day with a few minutes of prayer or meditation helps you to be intentional. Let’s begin! [More]

Infliximab, Biologics: Infusion Precautions

Biologics products have been developed to treat undesirable immune responses caused by chronic systemic inflammatory conditions. The immune system consists of a vast network of cells, tissues and organs that all perform specific functions to help keep the “host” in a state of equilibrium. Infliximab is a monoclonal antibody tumor necrosis factor α (TNF) inhibitor. That has been used to slow the progression of several inflammatory conditions, such as rheumatoid arthritis by blocking the activation of TNF, target specific therapy. [More]